Zhejiang NHU Company Ltd. (SHE:002001)
China · Delayed Price · Currency is CNY 35.39
+0.86 (2.49%)
Apr 28, 2026, 3:04 PM CST
Zhejiang NHU Company Revenue
In the year 2025, Zhejiang NHU Company had annual revenue of 22.25B CNY with 2.97% growth. Zhejiang NHU Company had revenue of 5.61B in the quarter ending December 31, 2025, a decrease of -3.75%.
Revenue
22.25B
Revenue Growth
+2.97%
P/S Ratio
4.88
Revenue / Employee
1.93M
Employees
11,508
Market Cap
108.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.25B | 641.77M | 2.97% |
| Dec 31, 2024 | 21.61B | 6.49B | 42.95% |
| Dec 31, 2023 | 15.12B | -817.45M | -5.13% |
| Jan 1, 2023 | 15.93B | 1.02B | 6.82% |
| Jan 1, 2022 | 14.92B | 4.60B | 44.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 44.06B |
| Shanghai Fosun Pharmaceutical (Group) | 41.66B |
| Yunnan Baiyao Group Co.,Ltd | 41.19B |
| China Resources Sanjiu Medical & Pharmaceutical | 32.88B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 32.56B |
| Humanwell Healthcare (Group) | 23.96B |
| Beijing Tongrentang | 17.26B |
| Changchun High-Tech Industry (Group) | 11.67B |